Journal of Affective Disorders
Volume 87, Issue 1 , Pages 57-63 , July 2005

Contributing factors to changes of cerebral blood flow in major depressive disorder

  • Hirochika Ohgami

      Affiliations

    • Department of Neuropsychiatry, Oita University Faculty of Medicine, Hasama-Machi, Oita 879-5593, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 97 586 5823; fax: +81 97 549 3583.
  • ,
  • Haruo Nagayama

      Affiliations

    • Department of Neuropsychiatry, Oita University Faculty of Medicine, Hasama-Machi, Oita 879-5593, Japan
  • ,
  • Jotaro Akiyoshi

      Affiliations

    • Department of Neuropsychiatry, Oita University Faculty of Medicine, Hasama-Machi, Oita 879-5593, Japan
  • ,
  • Kounosuke Tsuchiyama

      Affiliations

    • Department of Neuropsychiatry, Oita University Faculty of Medicine, Hasama-Machi, Oita 879-5593, Japan
  • ,
  • Shogo Komaki

      Affiliations

    • Department of Neuropsychiatry, Oita University Faculty of Medicine, Hasama-Machi, Oita 879-5593, Japan
  • ,
  • Hajime Takaki

      Affiliations

    • Department of Radiology, Oita University Faculty of Medicine, Hasama-Machi, Oita 879-5593, Japan
  • ,
  • Hiromu Mori

      Affiliations

    • Department of Radiology, Oita University Faculty of Medicine, Hasama-Machi, Oita 879-5593, Japan

Received 22 September 2004 ,Accepted 3 March 2005.

References 

  1. American Psychiatric Association . Diagnostic and statistical mental disorder. 4th-ed.. Washington, DC: APA; 1980;
  2. Anand A, Shekhar A. Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala. Ann. N.Y. Acad. Sci. 2003;985:370–388
  3. Austin MP, Dougall N, Ross M, Murray C, O'Carroll RE, Moffoot A, et al. Single photon emission tomography 99mTc-exametazime in major depression and depression and the pattern of brain activity underlying the psychotic/neurotic continuum. J. Affect. Disord. 1992;26:31–44
  4. Bench CJ, Frackowiak RSJ, Dolan RJ. Changes in regional cerebral blood flow on recovery from depression. Psychol. Med. 1995;25:247–251
  5. Bonne O, Krausz Y, Gorfine M, Karger H, Gelfin Y, Shapira B, et al. Cerebral hypoperfusion in medication resistant, depressive patients assessed by Tc99m HMPAO SPECT. J. Affect. Disord. 1996;41:163–171
  6. Buchsbaum MS, Wu J, DeLisi LE, Holcomb H, Kessler R, Johnson J, et al. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J. Affect. Disord. 1986;10:137–152
  7. Curran SM, Murray CM, Van. Beck M, Dougall N, O'Carroll RE, Austin MP, et al. A single photon emission tomography study of regional brain function in elderly patients with major depression and with Alzheimer-type dementia. Br. J. Psychiatry. 1993;163:155–165
  8. Delvenne V, Delecluse F, Hubain PP, Schoutens A, De Maertelaer V, Mendlewicz J. Regional cerebral blood flow in patients with affective disorders. Br. J. Psychiatry. 1990;157:359–365
  9. Dolan RJ, Bench CJ, Liddle PF, Friston KJ, Frith CD, Grasby PM, et al. Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity?. J. Neural Neurosurg. Psychiatry. 1993;56:1290–1294
  10. Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME. A functional anatomical study of unipolar depression. J. Neurosci. 1992;12:3628–3641
  11. Drevets WC, Price JL, Simpson JR, Todd RD, Reich T, Vannier M, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 1997;386:824–827
  12. Goodwin GM. Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. J. Psychopharmacol. 1997;11:115–122
  13. Goodwin GM, Austin MP, Dougall N, Ross M, Murray C, O'Carroll RE, et al. State changes in brain activity shown by the uptake of 99mTc-exametazime with single photon emission tomography in major depression before and after treatment. J. Affect. Disord. 1993;29:243–253
  14. Graff-Guerrero A, Gonzalez-Olvera J, Mendoza-Espinosa Y, Vaugier V, Garcia-Reyna JC. Correlation between cerebral blood flow and items of the Hamilton rating scale for depression in antidepressant-naive patients. J. Affect. Disord. 2004;80:55–63
  15. Grasby PM. Imaging strategies in depression. J. Psychopharmacol. 1999;13:346–351
  16. Kennedy SH, Javanmard M, Vaccarino FJ. A review of functional neuroimaging in mood disorders: positron emission tomography and depression. Can. J. Psychiatry. 1997;42:467–475
  17. Kocmur M, Milcinski M, Budihna NV. Evaluation of brain perfusion technetium-99m bicisate single-photon emission tomography in patients with depressive disorder before and after treatment. Eur. J. Nucl. Med. 1998;25:1412–1414
  18. Kumar A, Newberg A, Alavi A, Berlin J, Smith R, Reivich M. Regional cerebral glucose metabolism in late life depression and Alzheimer disease. A preliminary positron emission tomography study. Proc. Natl. Acad. Sci. U. S. A. 1993;90:7019–7023
  19. Lerer B, Krausz Y. Antidepressant response and cerebral blood flow in patients with major depression. Neuropsychopharmacology. 1994;10:3S
  20. Lesser IM, Mena I, Boone KB, Miller BL, Mehringer CM, Wohl M. Reduction of cerebral blood flow in older depressed patients. Arch. Gen. Psychiatry. 1994;51:677–686
  21. Matsuda H, Tsuji S, Shuke N, Sumiya H, Tonami N, Hisada K. A quantitative approach to technetium-99m hexamethylpropylene amine oxime. Eur. J. Nucl. Med. 1992;19:195–200
  22. Matsuda H, Tsuji S, Shuke N, Sumiya H, Tonami N, Hisada K. Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime. Eur. J. Nucl. Med. 1993;20:391–401
  23. Matsuda H, Yagishita A, Tsuji S, Hisada K. A quantitative approach to technetium-99m ethyl cysteinate dimmer. Eur. J. Nucl. Med. 1995;22:633–637
  24. Mayberg HS, Lewis PJ, Regenold W, Wagner HN. Paralimbic hypoperfusion in unipolar depression. J. Nucl. Med. 1994;35:929–934
  25. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, et al. Reciprocal limbic-cortical function and negative mood; converging PET findings in depression and normal sadness. Am. J. Psychiatry. 1999;156:675–682
  26. Navarro V, Gasto C, Lomena F, Mateos JJ, Portella MJ, Masana G, et al. No brain perfusion impairment at long-term follow-up in elderly patients treated with electroconvulsive therapy for major depression. J. ECT. 2004;20:89–93
  27. Navarro V, Gasto C, Lomena F, Mateos JJ, Portella MJ, Massana G, et al. Frontal cerebral perfusion after antidepressant drug treatment versus ECT in elderly patients with major depression: a 12-month follow-up control study. J. Clin. Psychiatry. 2004;65:656–661
  28. Navarro V, Gasto C, Lomena F, Torres X, Mateos JJ, Portella MJ, et al. Prognostic value of frontal functional neuroimaging in late-onset severe major depression. Br. J. Psychiatry. 2004;184:306–311
  29. Nobler MS, Sackeim HA, Prohovnik I, Moeller JR, Mukherjee S, Schnur DB, et al. Regional cerebral blood flow in mood disorders: III. Treatment and clinical response. Arch. Gen. Psychiatry. 1994;51:884–897
  30. Ogura A, Morinobu S, Kawakatsu S, Totsuka S, Komatani A. Changes in regional brain activity in major depression after successful treatment with antidepressant drugs. Acta Psychiatr. Scand. 1998;98:54–59
  31. Petracca G, Migliorelli R, Vazquez S, Starkstein SE. SPECT findings before and after ECT in a patient with major depression and Cotard syndrome. J. Neuropsychiatry Clin. Neurosci. 1995;7:505–507
  32. Sackeim HA. Functional brain circuits in major depression and remission. Arch. Gen. Psychiatry. 2001;58:649–650
  33. Smith GS, Reynolds CF, Pollock B, Derbyshire S, Nofzinger E, Dew MA, et al. Cerebral glucose metabolic to combined total sleep deprivation and antidepressant treatment in geriatric depression. Am. J. Psychiatry. 1999;156:683–689
  34. Vasile RG, Schwartz RB, Garada B, Holman BL, Alpert M, Davidson PB, et al. Focal cerebral perfusion defects demonstrated by 99mTc-hexamethyl-propyleneamine oxime SPECT in elderly depressive patients. Psychiat. Res. Neuroimag. 1996;67:59–70

PII: S0165-0327(05)00077-7

doi: 10.1016/j.jad.2005.03.004

Journal of Affective Disorders
Volume 87, Issue 1 , Pages 57-63 , July 2005